Clinically relevant improvements in asthma-related quality of life in patients receiving omalizumab as add-on therapy

被引：1
|
作者：
Busse, W
Fox, H
Surrey, K
Maykut, R
Reisner, C
机构：
[1] Univ Wisconsin, Dept Med, Madison, WI 53706 USA
[2] Novartis Horsham Res Ctr, Horsham, W Sussex, England
[3] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.033
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
30
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] Add-on Therapy with Rasagiline: Improvement in Quality of Life and Motor Fluctuations in Parkinsonian Patients
    Reichmann, H.
    Jost, W. H.
    Klasser, M.
    AKTUELLE NEUROLOGIE, 2009, 36 (02) : 55 - 59
  • [32] Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan
    Weycker, Derek
    Keskinaslan, Abdulkadir
    Levy, Drew
    Oster, Gerry
    JOURNAL OF HYPERTENSION, 2006, 24 : 317 - 317
  • [33] Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan
    Weycker, Derek
    Keskinaslan, Abdulkadir
    Levy, Drew Griffin
    Edelsberg, John
    Kartashov, Alex
    Oster, Gerry
    BLOOD PRESSURE, 2008, 17 : 5 - 12
  • [34] Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
    Luis Manuel Entrenas Costa
    Francisco Casas-Maldonado
    José Gregorio Soto Campos
    Alicia Padilla-Galo
    Alberto Levy
    Francisco Javier Álvarez Gutiérrez
    Ana P. Gómez-Bastero Fernández
    Concepción Morales-García
    Rocío Gallego Domínguez
    Gustavo Villegas Sánchez
    Luis Mateos Caballero
    Antonio Pereira-Vega
    Cayo García Polo
    Gerardo Pérez Chica
    Juan José Martín Villasclaras
    PharmacoEconomics - Open, 2019, 3 : 333 - 342
  • [35] Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
    Entrenas Costa, Luis Manuel
    Casas-Maldonado, Francisco
    Soto Campos, Jose Gregorio
    Padilla-Galo, Alicia
    Levy, Alberto
    Alvarez Gutierrez, Francisco Javier
    Gomez-Bastero Fernandez, Ana P.
    Morales-Garcia, Concepcion
    Gallego Dominguez, Rocio
    Villegas Sanchez, Gustavo
    Mateos Caballero, Luis
    Pereira-Vega, Antonio
    Garcia Polo, Cayo
    Perez Chica, Gerardo
    Martin Villasclaras, Juan Jose
    PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 333 - 342
  • [36] Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma
    Luskin, Allan T.
    Chipps, Bradley E.
    Rasouliyan, Lawrence
    Miller, Dave P.
    Haselkorn, Tmirah
    Dorenbaum, Alejandro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (05): : 544 - +
  • [37] Improvements in Lung Function With Tiotropium as Add-On Controller Therapy to ICS plus LABA for Patients With Symptomatic Severe Asthma
    Doherty, Dennis E.
    Tashkin, Donald P.
    Harrison, Tim W.
    Engel, Michael
    Schmidt, Hendrik
    Moroni-Zentgraf, Petra
    Kerstjens, Huib A. M.
    CHEST, 2013, 144 (04)
  • [38] Ethnicity as a determinant of asthma-related quality of life in a multiracial country
    Loh, L. C.
    Teh, P. N.
    Seth, K. D.
    Raman, S.
    Vijayasingham, P.
    Thayaparan, T.
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2006, 18 (01) : 49 - 55
  • [39] Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma
    Abidi, Afroz
    Gupta, Surabhi
    Agarwal, Manu
    Bhalla, H. L.
    Saluja, Mahip
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (08) : HC19 - HC24
  • [40] Add-on omalizumab improves asthma control across multiple measures of response in patients with severe persistent allergic asthma
    Berger, W
    Fox, H
    Ayre, G
    Blogg, M
    Massanari, M
    Reisner, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S8 - S8
12345